evidence table
Ginger Menstrual Pain Meta-Analysis Evidence Table
Structured evidence table for Ginger Menstrual Pain Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Ginger Menstrual Pain Meta-Analysis | Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review. | 1 | Dashti S (2026) | Herbal compounds in the treatment of polycystic ovary syndrome: an updated systematic review. |
| Ginger Menstrual Pain Meta-Analysis | NSAIDs have been found to be more effective than placebo in relieving pain in women with primary dysmenorrhea, but they increase the risk of adverse effects, such as mild neurological symptoms (headache, drowsiness, dizziness) and gastrointestinal symptoms (nausea, indigestion). | 3 | Ma Wenyi (2026) | Complementary and alternative therapies in the treatment of primary dysmenorrhea |
| Ginger Menstrual Pain Meta-Analysis | However, when combined OCP is used, there is an additional deep vein thrombosis (DVT) in every 1,000 women, and a higher risk is observed in users aged 6–12 months before use and over 40 years old (). | 3 | Ma Wenyi (2026) | Complementary and alternative therapies in the treatment of primary dysmenorrhea |
| Ginger Menstrual Pain Meta-Analysis | In addition to the known thrombotic effect of estrogen, the type of progesterone may also affect the risk of DVT, although the data are limited and contradictory (–). | 3 | Ma Wenyi (2026) | Complementary and alternative therapies in the treatment of primary dysmenorrhea |
| Ginger Menstrual Pain Meta-Analysis | 1 2 Figure 1 Primary dysmenorrhea is a menstrual disorder characterized by pain that begins shortly before or at the onset of menstruation and can last up to 72 h. | 3 | Ma Wenyi (2026) | Complementary and alternative therapies in the treatment of primary dysmenorrhea |
Source documents